Recalls and alerts more than 4 years old are automatically archived. While this information can still be accessed in the database, it has not been altered or updated since it was archived. Web pages that are archived on the Web are not subject to the Government of Canada Web Standards. As per the Communications Policy of the Government of Canada, you can request alternate formats by contacting us.

Contaminated Foaming Hand Soap Recalled Due to Dangerous Bacteria

Starting date:
October 15, 2012
Posting date:
October 15, 2012
Type of communication:
Advisory
Subcategory:
Miscellaneous
Source of recall:
Health Canada
Issue:
Product Safety
Identification number:
RA-15063

Avmor Ltd. is voluntarily recalling one lot of its Antimicrobial Foaming Hand Soap (Triclosan 0.3%) due to microbial contamination.

Products affected

Antimicrobial Foaming Hand Soap (Triclosan 0.3%)
1L clear plastic cartridge (used with a foaming pump)
Drug Identification Number: DIN 02319144
Lot number F121392032

What you should do

  • Do not use Avmor Ltd.'s Antimicrobial Foaming Hand Soap (Triclosan 0.3%) or any other antimicrobial foaming hand soap that you cannot identify from a dispenser.
  • Speak to your healthcare practitioner if you have used the affected product or have concerns about your health.
  • Schools, offices, hospitals and consumers should contact the company, Avmor Ltd., at 1-450-629-8074 extension 2360 for more information about the recall.
  • Report any adverse reaction you suspect may be related to this product to Health Canada (see below).

Who is affected

Canadians, who have bought or used this product, especially those with compromised immune systems, including those with cystic fibrosis, HIV/AIDS, cancer, burns, diabetes and severe lung disease.

Background

The bacteria identified in the tested sample are from the Pseudomonas group. For someone whose immune system has been weakened by other serious conditions, especially cystic fibrosis, HIV/AIDS, severe lung disease, burns, cancer, or diabetes, these bacteria can cause serious infections including pneumonia, bone infections, urinary tract infections, gastrointestinal infections, meningitis, and blood infections.

In healthy consumers, Pseudomonas group bacteria can enter the body through cuts, lesions and open burn wounds and may cause local infections, abscesses and blood infection. Additionally, the Pseudomonas species is also associated with eye and outer ear infections.

No adverse reactions involving the use of this product have been reported to Health Canada. The company has also confirmed it has received no adverse reactions reports involving the affected product to date.

Affected products

Antimicrobial Foaming Hand Soap

Hazard identified

Product testing undertaken by Health Canada detected bacteria (Pseudomonas aeruginosa) that may pose serious health risks to people, especially those with weakened immune systems. This product is used in private and public settings (offices, schools and hospitals) by individuals.


Report health or safety concerns

  • Call toll-free at 1-866-234-2345
  • Visit MedEffect Canada's Web page on Adverse Reaction Reporting for information on how to report online, by mail or by fax.

Stay connected with Health Canada and receive the latest advisories and product recalls using social media.

Expanded Recall of Contaminated Foaming Hand Soap

2012-10-18 | Health products, Consumer products

Advisory

Expanded Recall of X3 Clean Alcohol-Free Foaming Hand Sanitizer

2012-11-06 | Consumer products, Health products

Advisory

Media enquiries

Health Canada
(613) 957-2983

Public enquiries

(613) 957-2991
1-866 225-0709

What Health Canada is doing

Health Canada is monitoring the recall and the company's investigation to identify and address the root cause of the contamination.

Images

Select thumbnail to enlarge - opens in a new window


For more information

Consumers and health professionals wanting more information about this advisory from Health Canada can contact the Public Enquiries Line at 613-957-2991, or toll free at 1-866-225-0709.

Media enquiries related to this Advisory should be directed to Health Canada Media Relations at 613-957-2983.